Quarterly Results • Search Archive

Wanbury Limited
Results, Financials & Updates

Follow Wanbury Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

1 published deep dive 1 quarter 1 sector

Company Overview

Wanbury Limited: latest results and financials

Latest covered quarterQ1 FY27NSE: WANBURY
Revenue from operations₹165.58 CrReported in the latest covered quarter
Profit after tax₹3.24 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

Wanbury Limited is an established pharmaceutical company operating across active pharmaceutical ingredients (APIs) and domestic branded formulations, backed by over 37 years of operating history. The company maintains a dual revenue-stream structure, with APIs contributing the majority of top-line revenue through global exports to over 50 countries, and branded formulations serving the domestic Indian market across acute and chronic therapeutic categories.

← All quarterly results

Quarter history

Wanbury Limited Results & Financials

Latest Nivata coverage: Q1 FY27 · revenue ₹165.58 Cr · PAT ₹3.24 Cr.

Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.